Addressing complexities in recovery with severe mental illness (SMI)

A4i (App4Independence) is a patent-pending, validated, digital therapeutic with a regulatory pathway. A4i is a mobile application and portal/EMR integration platform currently focused on psychosis spectrum illnesses. Co-designed with patients and clinicians to support, reduce isolation and predict likelihood of relapse in complex behavioural health, A4i’s pipeline and IP address addictions and other complex behavioural health challenges. A joint venture between Canada’s largest mental health teaching hospital, CAMH, and the MEMOTEXT digital therapeutics platform, A4i has secured early pilot projects across North America and has deep expertise in mental and digital health.

To learn more, visit: www.a4i.me